Mukesh Bansal’s Cure.fit acquires US-based fitness company Onyx

Bengaluru-based health and fitness startup Cure.fit announced that it has acquired Onyx, a California-based fitness company, to bolster its digital offerings in India.

The company said that this would also help improve their international business.

Onyx specialises in body tracking technology and personalisation of workout feedback. Onyx is also one of the highest-rated apps in the fitness domain that has seen rapid user growth over the course of the last year.

Commenting on the acquisition, Mukesh Bansal, Co-Founder, Cure.fit, said: “The 20s will be the decade of digital health. Onyx will accelerate our efforts towards building a hardware agnostic AI-led platform that offers guided content on physical & mental wellness and nutrition all at the same place. Users will get a personalised experience with high-quality tech and human touch, and will be able to achieve their fitness goals from the comfort of their homes without spending on expensive hardware.”

While talking about the acquisition, Co-founder of Onyx, Asaf Avidan Antonir said: “Our mission at Onyx has always been to make truly personalised and connected fitness accessible to anyone. We are excited to be joining Cure.fit to contribute to this shared mission, and together bring incredible digital fitness experiences to a global audience even faster.”

Cure.fit was founded in 2016 by Mukesh Bansal, co-founder of fashion retailer Myntra, and Ankit Nagori, former Chief Business Officer of Flipkart.

Cure.fit offers both online and offline experiences across fitness, nutrition and mental wellbeing through its 4 products, i.e, cult.fit, eat.fit, mind.fit & care.fit.

+ posts

HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.

What's your take on this post ? Comment: